Patents Assigned to LambdaVision Incorporated
  • Method for stimulating retinal cells and treating vision loss
    Patent number: 11998443
    Abstract: Protein-based subretinal implants offer a new approach to restoring vision for patients blinded by conditions such as age-related macular degeneration (AMD) and retinitis pigmentosa (RP). The present invention relates to bacteriorhodopsin-based (BR-based) retinal implants that can be implanted in a subretinal position to replace degenerated photoreceptor cells.
    Type: Grant
    Filed: May 8, 2018
    Date of Patent: June 4, 2024
    Assignee: LambdaVision Incorporated
    Inventors: Robert R Birge, Nicole Wagner, Jordan A Greco